ALV Form 4 Filed: Staffan Olsson Reports Multiple RSU and Performance Grants
Rhea-AI Filing Summary
Staffan Olsson, Executive Vice President, Operations at Autoliv Inc. (ALV), reported equity awards on 09/23/2025 in a Form 4 filed via power of attorney. The filing shows multiple restricted stock unit (RSU) awards and performance-based RSUs that were acquired (recorded as dividend equivalents added) with $0 exercise price. The filing lists resulting beneficial ownership amounts following the grants: 713.7864, 203.6214, 237.2422, 186.5916, and 492.0841 shares for the respective awards. Several RSUs have specified vesting/exercise dates of 02/15/2026, 02/20/2027, and 02/21/2028. Performance-based RSUs vest after completion of three one-year performance periods ending December 31, 2025 or December 31, 2026 and certification by the committee.
Positive
- Equity alignment: Grants align the executive’s compensation with shareholder outcomes through performance-based RSUs.
- Clarity of vesting: Vesting dates are specified (02/15/2026, 02/20/2027, 02/21/2028) and performance periods are defined, improving transparency.
- No cash outlay: Awards recorded with a $0 price indicate grant issuance rather than a purchase or sale.
Negative
- None.
Insights
TL;DR: Routine director/executive equity grants were recorded, increasing reported beneficial ownership with multi-year vesting.
The Form 4 documents non-cash equity awards to an executive-level officer, reflecting award accruals and dividend-equivalent RSUs rather than open-market purchases or sales. The awards carry $0 price and include both time-based RSUs with specific vesting dates and performance-based RSUs that vest upon multi-year performance period completion and committee certification. For investors, this is a standard compensation disclosure that adjusts insider ownership tallies but does not indicate disposals or changes in corporate control.
TL;DR: Grants combine performance and time-based RSUs with dividend-equivalent accruals and staggered vesting to retain and incent an executive.
The reported instruments include performance-based RSUs (2023 and 2024 grants) that vest after three one-year performance periods subject to committee certification, and multiple time-based RSUs with vesting in 2026–2028. Dividend equivalents were paid as additional RSUs per the award agreement. Structurally, these grants align pay with multi-year performance and retention objectives and are commonly used in executive compensation programs.